Rapamycin affects eIF-4E expression in rat myocardial fibroblasts infected by Coxsackievirus B3

Chinese Journal of Contemporary Pediatrics

Volumn 9, Issue 6, 2007, Pages 587-590

  Chen, Chen Yuan ^a   Sun, Yue Nu ^a   Yang, Zuo Cheng ^a   Long, Yan Qiong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Coxsackievirus B3; eI 4E; Myocardial fibroblasts; Rapamycin

Indexed keywords

INITIATION FACTOR 4E; RAPAMYCIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; COXSACKIE VIRUS B3; CYTOPLASM; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG TARGETING; FIBROBLAST; FIBROBLAST CULTURE; HEART MUSCLE CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS INFECTION; VIRUS MYOCARDITIS; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; EUKARYOTIC INITIATION FACTOR-4E; FIBROBLASTS; GENE EXPRESSION REGULATION; MYOCARDITIS; MYOCARDIUM; RATS; SIROLIMUS;

EID: 38049094947     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chinese source.
2. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction [J]. Circulation, 2005, 112 (13): 1965-1970.
3. Heymans S, Pauschinger M, De Palma A, Kallwellis-Opara A, Rutschow S, Swinnen M, et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis [J]. Circulation, 2006, 114(6):565-573.
4. Si X, Luo H, Morgan A, Zhang J, Wong J, Yuan J, et al. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release [J]. J Virol, 2005, 79(22):13875-13881.
5. Cunningham KA, Chapman NM, Carson SD. Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants [J]. Virus Res, 2003, 92(2):179-186.
6. Esfandiarei M, Luo H, Yanagawa B. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent [J]. J Virol, 2004, 78(8):4289-4298.
7. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease [J]. Nat Genet, 2005, 37(1): 19-24.
8. Chinese source.
9. Padalko E, Verbeken E, Matthys P, Aerts JL, De Clercq E, Neyts J. Mycophenolate mofetil inhibits the development of Coxsackie B3- virus- induced myocarditis in mice[J]. BMC Microbiol, 2003, 3: 25.
10. Chinese source.
11. Chinese source.
12. Chinese source.
13. Zautner AE, Korner U, Henke A, Badorff C, Schmidtke M. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection [J]. J Virol, 2003, 77 (18): 10071-10077.
14. Zautner AE, Jahn B, Hammerschimdt E, Wutzler P, Schmidtke M. N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells [J]. J Virol, 2006, 80(13):6629-6636.
15. Heim A, Canu A, Kirschner P, Simon T, Mall G, Hofschneider PH, et al. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts[J]. Infect Dis, 1992, 166(5): 958-965.
16. Heim A, Zeuke S, Weiss S, Ruschewski W, Grumbach IM. Transient induction of cytokine production in human myocardial myocardial fibroblasts by coxsackievirus B3 [J]. Circ Res, 2000, 86(7): 753-759.
17. Parent R, Kolippakkam D, Booth G, Beretta L. Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth [J]. Cancer Res, 2007, 67(9):4337-4345.
18. Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, et al. The akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation [J]. Cancer Res, 2007, 67 (9):4287-4294.